WHO ICTRP trial
Study on the efficacy and safety of Vericiguat in patients with heart failure…
ChiCTR2300077753 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300077753 |
|---|---|
| Public title | Study on the efficacy and safety of Vericiguat in patients with heart failure after myocardial infarction |
| Scientific title | Study on the efficacy and safety of Vericiguat in patients with heart failure after myocardial infarction |
| Primary sponsor | China-Japan Union Hospital of Jilin University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Heart failure after myocardial infarction |
| Interventions | Experimental group:Conventional treatment+ Vericiguat 2.5-10mg qd;Control group:Conventional treatment |
| Registration date | Nov 17, 2023 |
| Target size | Experimental group:125;Control group:125 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: